Medica provides private equity capital to emerging companies operating in the health care and life
sciences sector and looks to fund companies with exciting new technologies that satisfy needs of
large and growing markets. These companies utilize business models that offer substantial long-term
competitive advantages.
I N D U S T R Y
Pharmaceuticals
- Drug development.
- Drug delivery systems.
- Drug discovery enabling technologies.
- New screening technologies and Bio/Chemical tools.
Biotechnology
- Genomics, Proteomics and Glycomics.
- Bioinformatics and In-Silico biology.
- Tissue engineering and tissue regeneration.
Medical Technology & Medical Devices
- Medical and Surgical Instrumentation.
- Implantable devices.
- Disposable component based devices.
- Other technologies that offer significant clinical benefits and major value enhancement
over existing medical technologies.
Other Life Science Technologies
- Bioelectronics.
- Food technology.
- Agro/vet.
S T A G E
Seed, start-up, and later stage companies.
I N V E S T M E N T S I Z E
Initial investments in a single portfolio company may range from $500,000 to $3,000,000.
Medica maintains sufficient capital reserves for follow-on investments.
